Purple Biotech Ltd.

NASDAQ: PPBT · Real-Time Price · USD
2.43
0.12 (5.19%)
At close: Aug 15, 2025, 3:59 PM
2.28
-6.17%
After-hours: Aug 15, 2025, 04:48 PM EDT

Purple Biotech Income Statement

Financials in USD. Fiscal year is January - December.
Fiscal Year Q1 2025 Q4 2024 Q3 2024 Q2 2024 Q1 2024 Q4 2023 Q3 2023 Q2 2023 Q1 2023 Q4 2022 Q3 2022 Q2 2022 Q1 2022 Q4 2021 Q3 2021 Q2 2021 Q1 2021
Period Ending Mar 31, 2025 Dec 31, 2024 Sep 30, 2024 Jun 30, 2024 Mar 31, 2024 Dec 31, 2023 Sep 30, 2023 Jun 30, 2023 Mar 31, 2023 Dec 31, 2022 Sep 30, 2022 Jun 30, 2022 Mar 31, 2022 Dec 31, 2021 Sep 30, 2021 Jun 30, 2021 Mar 31, 2021
Revenue
n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a 500K
Cost of Revenue
62K 62K 196.00 196.00 196.00 196.00 120.00 120.00 120.00 120.00 n/a n/a n/a n/a n/a n/a n/a
Gross Profit
n/a n/a -196 -196 -196 -196 -120 -120 -120 -120 n/a n/a n/a n/a n/a n/a 500K
Operating Income
-8.01M -11.07M -16.32M -19.94M -21.61M -22.27M -22.61M -21.94M -13.21M -15.42M -13.27M -11.23M -18.45M -17.65M 8.5M 7.41M 8.88M
Interest Income
305K 346K 346K 924K 926K 1.11M 1.69M 1.23M 1.19M 969K 449K 269K 258K 320K 356.5K 381K 337.5K
Pretax Income
-3.95M -7.28M -11.72M -16.11M -18.86M -19.98M -21.16M -20.95M -19.35M -21.76M -20.18M -18.48M -18.57M -17.83M -14.12M -11.1M -21.36M
Net Income
-3.93M -7.24M -11.66M -16.03M -18.76M -19.88M -21.06M -20.85M -19.25M -21.67M -20.73M -19.04M -19.13M -18.38M -14.05M -11.02M -21.28M
Selling & General & Admin
2.61M 3M 3.52M 3.9M 4.46M 5.04M 5.74M 6.2M 6.27M 6.03M 5.94M 5.75M 5.78M 6.06M 6.4M 6.93M 6.48M
Research & Development
4.96M 7.62M 12.4M 15.64M 16.96M 17.03M 16.61M 15.49M 13.87M 16.32M 14.57M 12.9M 12.91M 11.96M 10.81M 11.2M 10.68M
Other Expenses
450K 450K 202K 202K n/a n/a 135K 135K 135K 135K 67K 67K 67K 67K n/a n/a n/a
Operating Expenses
8.01M 11.07M 16.32M 19.94M 21.61M 22.27M 22.61M 21.94M 20.39M 22.6M 20.59M 18.7M 18.73M 18.07M 13.7M 14.66M 25.48M
Interest Expense
570K 552K 552K 57K 181K 223K 241K 241K 144K 126K 177K 182K 233K 212K 143K 122K 20K
Selling & Marketing Expenses
n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a 1.66M 1.66M 1.66M 1.66M
Cost & Expenses
8.01M 11.07M 16.32M 19.94M 21.61M 22.27M 22.61M 21.94M 20.39M 22.6M 47.42M 45.53M 38.32M 37.66M 6.46M 7.41M 25.48M
Income Tax Expense
n/a n/a n/a n/a n/a n/a n/a n/a -7.11M -7.07M -7.07M -13.41M -13.48M -13.52M -13.54M -7.21M -39.5K
Shares Outstanding (Basic)
13.16K 2.59M 1.74M 1.38M 1.3M 1.23M 1.07M 1.05M 1.04M 924.08K 902.03K 894.21K 890.02K 1.02M 875.62K 876.03K 868.88K
Shares Outstanding (Diluted)
13.16K 2.59M 1.74M 1.38M 1.3M 1.23M 1.07M 1.05M 1.04M 924.08K 902.03K 894.21K 890.02K 1.02M 875.61K 876.51K 868.86K
EPS (Basic)
-34 -0.06 -0.1 -0.14 -0.16 -0.18 -0.2 -0.22 -0.2 -0.24 -5.18 -8.7 -12.8 -20 -15.78 -12.54 -54
EPS (Diluted)
-34 -0.06 -0.1 -0.14 -0.16 -0.18 -0.2 -0.22 -0.2 -0.24 -5.18 -8.7 -12.8 -20 -16.12 -12.66 -54
EBITDA
-3.71M -7.05M -11.14M -16.02M -18.64M -19.72M -20.78M -20.58M -19.07M -21.49M -19.93M -18.05M -18.09M -17.23M -17.33M -18.6M -17.22M
EBIT
-3.9M -7.24M -11.34M -16.22M -18.84M -19.92M -20.98M -20.77M -19.26M -21.69M -20.14M -18.28M -18.32M -17.46M -17.69M -18.85M -17.46M
Depreciation & Amortization
183K 186K 194K 195K 199K 197K 199K 196K 195K 200K 211K 227K 236K 231K 358K 250K 235K